Future unrelated medical costs need to be considered in cost effectiveness analysis

Research output: Research - peer-reviewArticle

New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers whom cost effectiveness is supposed to serve.
Original languageEnglish
JournalEuropean Journal of Health Economics
StateAccepted/In press - 12 Apr 2018

    Research areas

  • health care expenditure, cost effective, future medical costs

View graph of relations